Inc.;The Henry M. Jackson Foundation for the Advancement of Military Medicine
发明人:
Cui, Xinle,Snapper, Clifford M
申请号：
AU2018213378
公开号：
AU2018213378A1
申请日:
2018.01.26
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided are antigenic compositions and uses thereof that include at least two human herpesvirus (HHV) polypeptides involved in mediating HHV binding, fusion, and entry into host cells, such as gp350, gH, gL, and gB, or nucleic acids encoding the polypeptides. The two HHV polypeptides comprise any combination of: a gB polypeptide； a gp350 polypeptide； a gL polypeptide； and a gH polypeptide, and optionally any one or more of the following polypeptides: gp42, gM, gN, gl, gC, gE, gD, ORF68, BMRF-2, BDLF2, UL128, UL130, UL131A, and gpK8.1. Also disclosed are methods of inducing an immune response or treating or preventing an HHV infection in a subject by administering to the subject at least two of the HHV polypeptides or nucleic acid(s) encoding the same. Methods of passively transferring immunity using high-titer anti-HHV antibodies or immune cells are also disclosed.
